Mumbai, 9th June, 2025: Baroda BNP Paribas Asset Management India Private Limited (‘Baroda BNP Paribas AMC’) has launched its latest New Fund Offer (NFO) – Baroda BNP Paribas Health and Wellness Fund, which opens for subscription on June 9, 2025, and closes on June 23, 2025. This open-ended equity scheme will focus on companies that are expected to benefit from the rising demand in healthcare and wellness—an emerging megatrend both in India and globally.
The fund aims to capitalise on the multi-decade structural growth story in healthcare and wellness space. While India’s existing per capita healthcare expenditure is quite low compared to developed markets, it is expected to grow exponentially on the back of rising affordability, increasing awareness, longer life expectancy, and higher incidence of chronic diseases.
“Over the last century or so, average life expectancy in India has more than tripled. Throughout the life stages from a toddler to a septuagenarian, there is a constant need and expenditure towards one’s wellbeing. Given the a low starting base of per capita expenditure on healthcare, we see this sector as a multi decadal opportunity that seeks with promising prospects for investors,” said Suresh Soni, CEO, Baroda BNP Paribas AMC.
India is facing an alarming surge in chronic diseases. the incidence of cardiac ailments, diabetes, and cancer could grow by ~34–41% this decade. This unfortunate trend reinforces the need for robust preventive and curative healthcare systems, creating fertile ground for investment.
“India offers a $200 billion market cap opportunity with over 100 investible companies across pharma, diagnostics, Medtech, hospitals, insurance, and healthcare research,” said Sanjay Chawla, CIO – Equity, Baroda BNP Paribas AMC.
The Indian pharmaceutical industry is a global leader, supplying:
· Over 50% of Africa’s generic medicine requirements
40% of generics used in the US
25% of all drugs used in the UK
India also holds the highest share of USFDA-approved drugs globally.
The BSE Healthcare Index has consistently outperformed the BSE 500 TRI over the last 1, 3, 7, and 15 years, driven by stronger earnings growth. These gains span companies across all market caps—large, mid, and small. Source: MFI Explorer, Data as on April 30, 2025.
This thematic fund is suited for investors who have an investment horizon of 3 years or more. The fund offers investors the opportunity to participate in India’s growing health consciousness and invest in an evolving ecosystem of wellness-focused businesses.
Leave a Reply